NSE BSE
alembic pharma ltd stock

ALEMBIC PHARMA LTD Share Price

- - (%)
- NSE: APLLTD

ALEMBIC PHARMA LTD Share Price Update

As of the latest trading session, ALEMBIC PHARMA LTD share price is currently at 1083.45, which is up by 101.60 from its previous closing. Today, the stock has fluctuated between 989.10 and 1119.00. Over the past year, ALEMBIC PHARMA LTD has achieved a return of 48.29 %. In the last month alone, the return has been 13.11 %. Read More...

ALEMBIC PHARMA LTD Performance

Day Range

Low989.10 High1119.00
1082.55

52 Week Range

Low 652.20 High 1119.00
1082.55

ALEMBIC PHARMA LTD Share Price

25328

533573

APLLTD

img img img img
No Data Available

Open Price

991.00

Prev. Close

981.85

Volume (Shares)

5768813.00

Total traded value

62450.28

Upper Circuit

1178.20

Lower Circuit

785.50

Note: The current prices & values are delayed, Login to your account for live updates.

ALEMBIC PHARMA LTD Fundamentals


(Standalone)

Market Cap (Cr) 21296.63
PE Ratio (TTM) 28.98
Book Value / Share 249.73
Beta 0.75
ROE 14.30%
EPS (TTM) 33.86
Dividend Yield 1.12%
Net Profit Qtr (Cr) 201.87

ALEMBIC PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 1474.55
Operating Expense 1265.61
Net Profit 201.87
Net Profit Margin (%) 13.69
Earnings Per Share (EPS) 10.27
EBITDA 295.40
Effective Tax Rate (%) 6.61
Particulars DEC 2023 (Values in Cr)
Revenue 1588.39
Operating Expense 1334.99
Net Profit 233.24
Net Profit Margin (%) 14.68
Earnings Per Share (EPS) 11.87
EBITDA 340.44
Effective Tax Rate (%) 9.13
Particulars SEP 2023 (Values in Cr)
Revenue 1478.84
Operating Expense 1353.95
Net Profit 133.84
Net Profit Margin (%) 9.05
Earnings Per Share (EPS) 6.81
EBITDA 216.41
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 1332.27
Operating Expense 1246.58
Net Profit 97.53
Net Profit Margin (%) 7.32
Earnings Per Share (EPS) 4.96
EBITDA 177.57
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 1307.12
Operating Expense 1225.07
Net Profit 130.54
Net Profit Margin (%) 9.98
Earnings Per Share (EPS) 6.64
EBITDA 171.14
Effective Tax Rate (%) -55.38
Particulars MAR 2024 (Values in Cr)
Revenue 5874.06
Operating Expense 5201.15
Net Profit 666.48
Net Profit Margin (%) 11.34
Earnings Per Share (EPS) 33.91
EBITDA 1029.84
Effective Tax Rate (%) 5.36
Particulars MAR 2023 (Values in Cr)
Revenue 5149.00
Operating Expense 4806.62
Net Profit 346.73
Net Profit Margin (%) 6.73
Earnings Per Share (EPS) 17.64
EBITDA 667.88
Effective Tax Rate (%) -0.23
Particulars MAR 2022 (Values in Cr)
Revenue 5035.41
Operating Expense 4428.54
Net Profit 543.55
Net Profit Margin (%) 10.79
Earnings Per Share (EPS) 27.65
EBITDA 959.95
Effective Tax Rate (%) 17.39
Particulars MAR 2021 (Values in Cr)
Revenue 5051.44
Operating Expense 3718.36
Net Profit 1175.39
Net Profit Margin (%) 23.26
Earnings Per Share (EPS) 60.67
EBITDA 1581.96
Effective Tax Rate (%) 17.02
Particulars MAR 2020 (Values in Cr)
Revenue 4132.55
Operating Expense 3090.51
Net Profit 969.40
Net Profit Margin (%) 23.45
Earnings Per Share (EPS) 51.42
EBITDA 1327.65
Effective Tax Rate (%) 16.91
Particulars MAR 2024 (Values in Cr)
Book Value / Share 245.14
ROE % 13.40
ROCE % 12.93
Total Debt to Total Equity 0.13
EBITDA Margin 15.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share 222.36
ROE % 7.12
ROCE % 7.20
Total Debt to Total Equity 0.15
EBITDA Margin 12.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 266.47
ROE % 10.11
ROCE % 10.91
Total Debt to Total Equity 0.13
EBITDA Margin 17.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share 257.80
ROE % 26.91
ROCE % 25.51
Total Debt to Total Equity 0.28
EBITDA Margin 29.07
Particulars MAR 2020 (Values in Cr)
Book Value / Share 170.79
ROE % 26.97
ROCE % 22.79
Total Debt to Total Equity 0.48
EBITDA Margin 25.71
Particulars MAR 2024 (Values in Cr)
Book Value / Share 249.75
ROE % 14.30
ROCE % 14.13
Total Debt to Total Equity 0.13
EBITDA Margin 17.53
Particulars MAR 2023 (Values in Cr)
Book Value / Share 224.59
ROE % 7.15
ROCE % 6.98
Total Debt to Total Equity 0.15
EBITDA Margin 12.97
Particulars MAR 2022 (Values in Cr)
Book Value / Share 269.16
ROE % 10.46
ROCE % 11.38
Total Debt to Total Equity 0.12
EBITDA Margin 19.06
Particulars MAR 2021 (Values in Cr)
Book Value / Share 259.57
ROE % 25.96
ROCE % 24.67
Total Debt to Total Equity 0.27
EBITDA Margin 30.26
Particulars MAR 2020 (Values in Cr)
Book Value / Share 177.51
ROE % 32.00
ROCE % 26.48
Total Debt to Total Equity 0.45
EBITDA Margin 32.13
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 126.57
Total Assets 6445.58
Total Liabilities 6445.58
Total Equity 4818.20
Share Outstanding 196563124
Price to Book Ratio 3.93
Return on Assets (%) 9.55
Return on Capital (%) 11.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 82.27
Total Assets 6182.83
Total Liabilities 6182.83
Total Equity 4370.47
Share Outstanding 196563124
Price to Book Ratio 2.21
Return on Assets (%) 5.53
Return on Capital (%) 6.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 69.43
Total Assets 7122.03
Total Liabilities 7122.03
Total Equity 5237.54
Share Outstanding 196563124
Price to Book Ratio 2.75
Return on Assets (%) 7.31
Return on Capital (%) 8.88
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 105.84
Total Assets 6708.98
Total Liabilities 6708.98
Total Equity 5066.97
Share Outstanding 196563124
Price to Book Ratio 3.72
Return on Assets (%) 17.08
Return on Capital (%) 20.6
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 80.75
Total Assets 5989.05
Total Liabilities 5989.05
Total Equity 3190.45
Share Outstanding 188515914
Price to Book Ratio 3.01
Return on Assets (%) 13.83
Return on Capital (%) 16.78
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 26.49
Total Assets 6398.54
Total Liabilities 6398.54
Total Equity 4908.91
Share Outstanding 196563124
Price to Book Ratio 3.93
Return on Assets (%) 10.41
Return on Capital (%) 12.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 28.46
Total Assets 6130.42
Total Liabilities 6130.42
Total Equity 4414.30
Share Outstanding 196563124
Price to Book Ratio 2.21
Return on Assets (%) 5.65
Return on Capital (%) 6.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 21.90
Total Assets 7074.04
Total Liabilities 7074.04
Total Equity 5290.34
Share Outstanding 196563124
Price to Book Ratio 2.75
Return on Assets (%) 7.68
Return on Capital (%) 9.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 61.44
Total Assets 6643.47
Total Liabilities 6643.47
Total Equity 5101.81
Share Outstanding 196563124
Price to Book Ratio 3.72
Return on Assets (%) 16.50
Return on Capital (%) 19.58
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 37.13
Total Assets 5878.77
Total Liabilities 5878.77
Total Equity 3346.01
Share Outstanding 188515914
Price to Book Ratio 3.01
Return on Assets (%) 16.48
Return on Capital (%) 19.26
Particulars MAR 2024 (Values in Cr)
Net Income 631.83
Cash from Operations 823.05
Cash from Investing -320.61
Cash from Financing -437.86
Net change in Cash 44.73
Free Cash Flow 1150.52
Particulars MAR 2023 (Values in Cr)
Net Income 354.59
Cash from Operations 784.64
Cash from Investing -447.60
Cash from Financing -261.96
Net change in Cash 14.39
Free Cash Flow 1228.05
Particulars MAR 2022 (Values in Cr)
Net Income 625.39
Cash from Operations 675.78
Cash from Investing -371.97
Cash from Financing -217.35
Net change in Cash -36.97
Free Cash Flow 1101.42
Particulars MAR 2021 (Values in Cr)
Net Income 1368.08
Cash from Operations 1708.82
Cash from Investing -838.81
Cash from Financing -597.43
Net change in Cash 27.15
Free Cash Flow 2368.34
Particulars MAR 2020 (Values in Cr)
Net Income 999.82
Cash from Operations 685.24
Cash from Investing -731.63
Cash from Financing 154.86
Net change in Cash -127.64
Free Cash Flow 1420.13
Particulars MAR 2024 (Values in Cr)
Net Income 704.23
Cash from Operations 782.80
Cash from Investing -329.02
Cash from Financing -445.29
Net change in Cash -1.54
Free Cash Flow 1107.32
Particulars MAR 2023 (Values in Cr)
Net Income 345.93
Cash from Operations 784.04
Cash from Investing -460.98
Cash from Financing -261.16
Net change in Cash 8.11
Free Cash Flow 1227.30
Particulars MAR 2022 (Values in Cr)
Net Income 658.01
Cash from Operations 674.06
Cash from Investing -368.72
Cash from Financing -216.64
Net change in Cash -40.10
Free Cash Flow 1096.42
Particulars MAR 2021 (Values in Cr)
Net Income 1337.74
Cash from Operations 1628.92
Cash from Investing -835.72
Cash from Financing -533.76
Net change in Cash 19.00
Free Cash Flow 2285.91
Particulars MAR 2020 (Values in Cr)
Net Income 1166.79
Cash from Operations 736.54
Cash from Investing -822.31
Cash from Financing 166.13
Net change in Cash -116.43
Free Cash Flow 1364.73
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALEMBIC PHARMA LTD 982.55 31.51 4.00 19313.31 645.05 / 1093.05
BLISS GVS PHARMA LTD 116.00 12.68 1.25 1214.96 77.65 / 148.95
CIPLA LTD 1516.05 28.75 4.58 122423.77 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 200.05 0.00 2.03 588.77 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2552.80 65.86 24.32 43245.97 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALEMBIC PHARMA LTD 982.55 29.02 3.93 19313.31 645.05 / 1093.05
AMRUTAJAN HEALTH LTD 744.70 47.86 7.46 2152.97 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6625.00 110.79 23.26 16562.50 3715.05 / 7550.00
BLISS GVS PHARMA LTD 116.00 15.96 1.22 1214.96 77.65 / 148.95
ABBOTT INDIA LIMITED 28590.80 50.58 16.42 60755.45 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 985.80
  • 26 Days 938.60
  • 10 Days 974.80
  • 50 Days 949.20
  • 12 Days 964.10
  • 100 Days 957.40
  • 20 Days 946.70
  • 200 Days 777.70
983.03
PIVOT
First Resistance 996.52
Second Resistance 1011.18
Third Resistance 1024.67
First Support 968.37
Second Support 954.88
Third Support 940.22
RSI 64.96
MACD 25.42
Commodity Channel Index (CCI) 69.35
ADX 30.94
Williams % R -25.22

Over 1 Month

down

13.11

Over 3 Months

down

1.37

Over 6 Months

down

4.05

Over 1 Year

down

48.29

Over 3 Years

down

0.56

Over 5 Years

down

12.90

ALEMBIC PHARMA LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ALEMBIC PHARMA LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
18.02
Promoter Holdings
69.61
FII
4.31
DII
8.05
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Nirayu Limited Shareholding of Promoter and Promoter Group 7.0035435E7 35.63
Alembic Limited Shareholding of Promoter and Promoter Group 5.6097544E7 28.54
Life Insurance Corporation Of India Public Shareholding 8502500.0 4.33
Dsp Midcap Fund Public Shareholding 8252124.0 4.2
Chirayu Ramanbhai Amin Shareholding of Promoter and Promoter Group 4192529.0 2.13
Kotak Small Cap Fund Public Shareholding 3468355.0 1.76
Malika Chirayu Amin Shareholding of Promoter and Promoter Group 3005730.0 1.53
Udit Chirayu Amin Shareholding of Promoter and Promoter Group 1006980.0 0.51
Shaunak Chirayu Amin Shareholding of Promoter and Promoter Group 1006980.0 0.51
Pranav Chirayu Amin Shareholding of Promoter and Promoter Group 1009800.0 0.51
Gallup Trust (pranav Chirayu Amin) Shareholding of Promoter and Promoter Group 100100.0 0.05
Naintara Shaunak Amin Shareholding of Promoter and Promoter Group 80000.0 0.04
Inaaya Shaunak Amin Shareholding of Promoter and Promoter Group 80000.0 0.04
Satori Trust (chirayu Ramanbhai Amin) Shareholding of Promoter and Promoter Group 50100.0 0.03
Krupa Shaunak Amin Shareholding of Promoter and Promoter Group 50100.0 0.03
Barkha Pranav Amin Shareholding of Promoter and Promoter Group 50100.0 0.03
Samira Pranav Amin Shareholding of Promoter and Promoter Group 30000.0 0.02
Ranvir Pranav Amin Shareholding of Promoter and Promoter Group 30000.0 0.02
Tishya Udit Amin Shareholding of Promoter and Promoter Group 0.0 0.0
Viramya Packlight Llp Shareholding of Promoter and Promoter Group 900.0 0.0
Cra Family Trust (chirayu Ramanbhai Amin) Shareholding of Promoter and Promoter Group 100.0 0.0
Grace Star Trust (shaunak Chirayu Amin) Shareholding of Promoter and Promoter Group 100.0 0.0
Shreno Limited Shareholding of Promoter and Promoter Group 100.0 0.0
Laksh Trust (chirayu Ramanbhai Amin) Shareholding of Promoter and Promoter Group 100.0 0.0
Virsad Family Trust (pranav Chirayu Amin) Shareholding of Promoter and Promoter Group 200.0 0.0
Laburnum Family Trust (chirayu Ramanbhai Amin) Shareholding of Promoter and Promoter Group 200.0 0.0
Uday Education Society (biniti Trivedi) Shareholding of Promoter and Promoter Group 0.0 0.0
Bhailal Amin General Hospital (chirayu Ramanbhai Amin) Shareholding of Promoter and Promoter Group 0.0 0.0
Ujjval Vidyalaya (malika Chirayu Amin) Shareholding of Promoter and Promoter Group 0.0 0.0
Utkarsh Vidyakendra (malika Chirayu Amin) Shareholding of Promoter and Promoter Group 0.0 0.0
Arogyavardhini Society (malika Chirayu Amin) Shareholding of Promoter and Promoter Group 0.0 0.0
Vidyanidhi Trust (malika Chirayu Amin) Shareholding of Promoter and Promoter Group 0.0 0.0
Shreno Engineering Limited Shareholding of Promoter and Promoter Group 100.0 0.0
Shreno Publications Limited Shareholding of Promoter and Promoter Group 100.0 0.0
Alembic City Limited Shareholding of Promoter and Promoter Group 100.0 0.0
Paushak Limited Shareholding of Promoter and Promoter Group 855.0 0.0

ALEMBIC PHARMA LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-28 8.0 Final 2023-07-28 Equity shares 2022-08-17 10.0 Interim 2022-08-18 Equity shares 2021-07-19 14.0 Final 2021-07-21 Equity shares 2020-03-16 3.0 Special 2020-03-17 Equity shares 2020-03-16 7.0 Interim 2020-03-17 Equity shares 2019-07-18 5.5 Final 2019-07-22 Equity shares 2018-07-18 4.0 Final 2018-07-20 Equity shares 2017-07-11 4.0 Final 2017-07-13 Equity shares 2016-07-20 4.0 Final 2016-07-22 Equity shares 2015-07-22 3.5 Final 2015-07-24 Equity shares 2014-07-17 3.0 Final 2014-07-21 Equity shares 2013-07-29 2.5 Final 2013-07-31 Equity shares 2012-07-31 1.4 Final 2012-08-02 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ALEMBIC PHARMA LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ALEMBIC PHARMA LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Alembic Pharmaceuticals Ltd?

Answer Field

The share price of Alembic Pharmaceuticals Ltd for NSE is ₹ 1083.45 and for BSE is ₹ 1082.

What is the Market Cap of Alembic Pharmaceuticals Ltd?

Answer Field

The market cap of Alembic Pharmaceuticals Ltd for NSE is ₹ 21,296.63 Cr. and for BSE is ₹ 21,268.13 Cr. as of now.

What is the 52 Week High and Low of Alembic Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Alembic Pharmaceuticals Ltd for NSE is ₹ 1119.00 and ₹ 652.20 and for BSE is ₹ 1118.60 and ₹ 645.05.

How to Buy Alembic Pharmaceuticals Ltd share?

Answer Field

You can trade in Alembic Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Alembic Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 48.29%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader